Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882104-17-000127
Filing Date
2017-12-19
Accepted
2017-12-19 20:04:26
Documents
1
Period of Report
2017-12-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_151373185271780.html 4  
1 FORM 4 wf-form4_151373185271780.xml 4 3277
  Complete submission text file 0000882104-17-000127.txt   4748
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Issuer) CIK: 0000882104 (see all company filings)

EIN.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BIOTIME INC 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address
GARCIA PETER S (Reporting) CIK: 0001188956 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19756 | Film No.: 171265461